GEOVAX LABS INC- WARRANTS
GEOVAX LABS INC- WARRANTS
Action · US3736781192 · GOVXW (XNAS)
Aperçu Indicateurs financiers
0,04 USD
13,96 % 0,005 USD
NASDAQ (XNAS) · Cours et graphiques actuels sur MoneyPeak
10.06.2025 19:57

Cours actuels de GEOVAX LABS INC- WARRANTS

BourseTickerDeviseDernier échangeCoursVariation journalière
XNAS: NASDAQ
NASDAQ
GOVXW
USD
10.06.2025 19:57
0,04 USD
0,04 USD
+13,96 %

Performance

Jour Semaine Mois 3 mois 6 mois 1 an 5 ans
0,00 % 19,01 % -4,88 % -45,50 % -64,35 % 6,67 % -95,29 %

Profil de l'entreprise pour GEOVAX LABS INC- WARRANTS Action

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company is developing GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, it is also developing GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-MM02 treatment for malaria; GEO-EM01 for the treatment of fever viruses, such as Ebola, Sudan, and Marburg; GEO-LM01 for the treatment of Lassa fever. GeoVax Labs, Inc. has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; U.S. Department of Defense; Emory University; and the Burnet Institute. GeoVax Labs, Inc. was incorporated in 1988 and is headquartered in Smyrna, Georgia.

Données de l'entreprise

Nom GEOVAX LABS INC- WARRANTS
Société GeoVax Labs, Inc.
Symbole GOVXW
Site web https://www.geovax.com
Marché d'origine XNAS NASDAQ
ISIN US3736781192
Type de titre Action
Secteur Healthcare
Industrie Biotechnology
PDG Mr. David Alan Dodd
Capitalisation boursière 12 Mio
Pays États-Unis d'Amérique
Devise USD
Employés 0,0 T
Adresse 1900 Lake Park Drive, 30080 Smyrna

Symboles boursiers

Nom Symbole
NASDAQ GOVXW

Autres actions

Les investisseurs qui détiennent GEOVAX LABS INC- WARRANTS ont également les actions suivantes dans leur portefeuille :
KRED.F.WIED.22/26 MTN
KRED.F.WIED.22/26 MTN Obligation
XTRACK. ETC PLATIN 80
XTRACK. ETC PLATIN 80 ETC
La plateforme financière MoneyPeak suit et analyse les investissements et les portefeuilles. Du dépôt de titres à l'achat de crypto.
Utile, simple et gratuit. Actions, ETF, ETC, ETN, indices, fonds, obligations, certificats, devises, options, droits de souscription.
Mentions légales Protection des données Blog Communauté Retour d'information Changelog
Im App Store herunterladen Bei Google Play herunterladen
Tous droits réservés © LCP GmbH 2025